Vaccine. 2010 Apr 19;28(18):3247-56. Epub 2010 Feb 26.

Prime and boost immunization with influenza and adenovirus encoding the Toxoplasma gondii surface antigen 2 (SAG2) induces strong protective immunity.

Machado AV, Caetano BC, Barbosa RP, Salgado AP, Rabelo RH, Garcia CC, Bruna-Romero O, Escriou N, Gazzinelli RT.

Source

Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-910, MG, Brazil. amarok@cpqrr.fiocruz.br

Abstract

In this work, we explored an original vaccination protocol using recombinant influenza and adenovirus. We constructed recombinant influenza viruses harboring dicistronic NA segments containing the surface antigen 2 (SAG2) from Toxoplasma gondii under control of the duplicated 3' promoter. Recombinant influenza viruses were able to drive the expression of the foreign SAG2 sequence in cell culture and to replicate efficiently both in cell culture and in lungs of infected mice. In addition, mice primed with recombinant influenza virus and boosted with a recombinant adenovirus encoding SAG2 elicited both humoral and cellular immune responses specific for SAG2. Moreover, when immunized animals were challenged with the cystogenic P-Br strain of T. gondii, they displayed up to 85% of reduction in parasite burden. These results demonstrate the potential use of recombinant influenza vectors harboring the dicistronic segments in the development of vaccines against infectious diseases.

PMID:: 20189485; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Immunization - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice. [Hum Gene Ther. 2006]
Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice.
Caetano BC, Bruña-Romero O, Fux B, Mendes EA, Penido ML, Gazzinelli RT. Hum Gene Ther. 2006 Apr; 17(4):415-26.
Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii. [Parasite Immunol. 2005]
Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
Cong H, Gu QM, Jiang Y, He SY, Zhou HY, Yang TT, Li Y, Zhao QL. Parasite Immunol. 2005 Jan-Feb; 27(1-2):29-35.
Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. [Vaccine. 2011]
Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
Dziadek B, Gatkowska J, Brzostek A, Dziadek J, Dzitko K, Grzybowski M, Dlugonska H. Vaccine. 2011 Jan 17; 29(4):821-30. Epub 2010 Nov 16.
DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB/c mice. [Parasit Vectors. 2011]
DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB/c mice.
Sun XM, Zou J, A A ES, Yan WC, Liu XY, Suo X, Wang H, Chen QJ. Parasit Vectors. 2011 Nov 9; 4:213. Epub 2011 Nov 9.
Review Vaccines against Toxoplasma gondii: challenges and opportunities. [Mem Inst Oswaldo Cruz. 2009]
Review Vaccines against Toxoplasma gondii: challenges and opportunities.
Jongert E, Roberts CW, Gargano N, Förster-Waldl E, Petersen E. Mem Inst Oswaldo Cruz. 2009 Mar; 104(2):252-66.

See reviews... See all...

Cited by 1 PubMed Central article

Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201. [Vaccine. 2011]
Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201.
Cong H, Mui EJ, Witola WH, Sidney J, Alexander J, Sette A, Maewal A, McLeod R. Vaccine. 2011 Jan 17; 29(4):754-62. Epub 2010 Nov 21.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Prime and boost immunization with influenza and adenovirus encoding the Toxoplas...
Prime and boost immunization with influenza and adenovirus encoding the Toxoplasma gondii surface antigen 2 (SAG2) induces strong protective immunity.
Vaccine. 2010 Apr 19 ;28(18):3247-56. Epub 2010 Feb 26 .

PubMed
Carotid artery stenting compared with endarterectomy in patients with symptomati...
Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial.
Lancet. 2010 Mar 20 ;375(9719):985-97. Epub 2010 Feb 25 .

PubMed
Naturopathy and the primary care practice.
Naturopathy and the primary care practice.
Prim Care. 2010 Mar ;37(1):119-36.

PubMed
Gamma- and delta-tocotrienols exert a more potent anticancer effect than alpha-t...
Gamma- and delta-tocotrienols exert a more potent anticancer effect than alpha-tocopheryl succinate on breast cancer cell lines irrespective of HER-2/neu expression.
Life Sci. 2010 Apr 24 ;86(17-18):668-75. Epub 2010 Feb 25 .

PubMed
Rapid generation of a well-matched vaccine seed from a modern influenza A virus ...
Rapid generation of a well-matched vaccine seed from a modern influenza A virus primary isolate without recourse to eggs.
Vaccine. 2010 Apr 9 ;28(17):2973-9. Epub 2010 Feb 25 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: